Tea beverage in chemoprevention of prostate cancer: a mini-review.
Because prostate cancer has a long latency period and is typically diagnosed in elderly men, it represents an ideal candidate disease for chemoprevention. Therefore, even a modest delay achieved through intervention could have a significant impact on the outcome of this disease. Epidemiological and laboratory studies have provided convincing evidence that diet, genetic factors, and lifestyle are major causes of prostate cancer. Although surgery, radiotherapy, and hormone therapy are the most widely accepted curative options for a selected group of patients suffering from prostate cancer, the side effects of these treatments are many. In recent years, many dietary agents have been being described that show a wide range of chemopreventive effects in cell culture and selected animal model systems of prostate carcinogenesis. One such agent is the beverage tea, which, next to water, is the most popularly consumed beverage in the world. The epidemiological studies and recent data, amassed from various laboratories around the world, provide evidence that tea polyphenols such as epigallocatechin-3-gallate, epigallocatechin, and epicatechin-3-gallate may have the potential to lower the risk of prostate cancer in the human population. Recently, it has been shown that green tea polyphenols, when given to TRAMP, a transgenic mouse model that mimics progressive forms of human prostate cancer, exert remarkable preventive effects against prostate cancer development. Chemoprevention of prostate cancer by tea polyphenols appears to occur through the modulation of various molecular targets. This article attempts to address the issue of the possible use of tea, especially green tea, for the chemoprevention of prostate cancer.
Saleem
Mohammad
M
Department of Dermatology, University of Wisconsin, 1300 Medical Science Center, Madison, WI 53706, USA.
Adhami
Vaqar Mustafa
VM
Siddiqui
Imtiaz Ahmad
IA
Mukhtar
Hasan
H
D000728:Androgens / Q000096:biosynthesis; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage; D028241:Camellia sinensis / Q000737:chemistry; D018890:Chemoprevention; D002986:Clinical Trials as Topic; D005419:Flavonoids / Q000008:administration & dosage / Q000032:analysis; D015870:Gene Expression; D006801:Humans; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D010636:Phenols / Q000008:administration & dosage / Q000032:analysis; D018515:Plant Leaves / Q000737:chemistry; D059808:Polyphenols; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D011944:Receptors, Androgen; D013662:Tea / Q000737:chemistry
D000728:Androgens; D000975:Antioxidants; D005419:Flavonoids; D010636:Phenols; D059808:Polyphenols; D011944:Receptors, Androgen; D013662:Tea; D017430:Prostate-Specific Antigen